Rephonic
Artwork for Lung Cancer Update

Lung Cancer Update

Dr. Neil Love
Non-Small Cell Lung Cancer
Immunotherapy
Lung Cancer
Small Cell Lung Cancer
Chemotherapy
Pembrolizumab
EGFR
Targeted Therapy
Osimertinib
EGFR Mutations
Antibody-Drug Conjugates
Antibody Drug Conjugates
Adjuvant Therapy
Clinical Trials
Neoadjuvant Chemotherapy
EGFR Mutation
Alk-Targeted Therapy
Adora Trial
Nivolumab
Pd-L1 Expression

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

PublishesTwice weeklyEpisodes359Founded20 years ago
Number of ListenersCategories
Health & FitnessScienceMedicine

Listen to this Podcast

Artwork for Lung Cancer Update

Latest Episodes

Featuring perspectives from Dr Joshua K Sabari, including the following topics:

• Jänne PA et al. Final analysis results and patient-reported outcomes from DESTINY-Lung02 — A dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan in patie... more

Featuring perspectives from Dr Joshua K Sabari, including the following topics:

• Heymach JV et al. Zongertinib in previously treated HER2-mutant non-small cell lung cancer. N Engl J Med 2025;392(23):2321-33. (0:00)

• Popat S et al. Zongertinib as f... more

Featuring perspectives from Dr Sarah B Goldberg, Dr Jonathan Goldman, Dr Joel W Neal, Dr Antonio Passaro and Dr Jacob Sands, moderated by Dr Sands, including the following topics:

• Introduction (00:00)

• Evolving First-Line Treatment for Metastati... more

Featuring an interview with Dr Mark Jeng and Dr Joshua K Sabari, including the following topics:

• Case: A woman in her late 90s with recurrent HER2-mutant metastatic non-small cell lung cancer (NSCLC) receives third-line zongertinib (0:00)

• Case: ... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Dr. Jamie Chaft
Memorial Sloan Kettering Cancer Center, New York City
Memorial Sloan Kettering Cancer Center
Episode: Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft
Courtney Arn
Panel speaker focusing on gynecologic cancers and ADCs
The Ohio State University / James Cancer Hospital
Episode: For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress
Jamie Carroll
Panel speaker focusing on cardiac assessment and toxicity of ADCs
Mayo Clinic
Episode: For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress
Eddie Garon
Panel speaker discussing lung cancer ADCs and case-based experience
David Geffen School of Medicine
Episode: For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress
Heather McArthur
Panel speaker discussing breast cancer ADCs and bystander effects
UT Southwestern Medical Center
Episode: For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress
Lyuda Bazhenova
Oncologist from UC San Diego Moores Cancer Center
UC San Diego Moores Cancer Center
Episode: Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
Corey Langer
Oncologist from Aberson Cancer Center
Aberson Cancer Center
Episode: Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
Sunil Gandhi
Oncologist from Florida Cancer Specialists
Florida Cancer Specialists
Episode: Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
Ross Wan
Oncologist discussing ROS-1 and RET inhibitors
(unspecified)
Episode: Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit

Host

Dr. Neil Love
Host of the series; Medical Oncologist with a focus on thoracic oncology and ongoing clinical discussions.

Reviews

4.6 out of 5 stars from 47 ratings
  • Medicine resident subscriber

    Third year medicine resident applying to Heme onc fellowship. I am interested in lung cancer and this podcast inspires critical thinking about patient management and provokes thought about the lung cancer literature. Uniquely has fantastic interviews with experts in the field. A great listen. I recommend this to anyone interested in oncology and interested in improving their knowledge of lung cancer management.

    Apple Podcasts
    5
    MG2MD
    United States8 years ago
  • Heldere informatie over longkanker

    Hier ben ik heel blij mee.

    Ik wou dat zoiets in het Nederlands bestond.

    Apple Podcasts
    5
    Thea 1953
    Netherlands14 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Some listeners benefit from real-world perspectives on trial data and treatment sequencing.
Listeners praise expert interviews and practical clinical insights that help translate complex literature into patient care.
The show is seen as a reliable source for nuanced discussions on targeted therapies and biomarkers.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#216
Mexico/Science

Talking Points

Recent interactions between the hosts and their guests.

Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft
Q: How should clinicians interpret the role of adjuvant immunotherapy after neoadjuvant chemoimmunotherapy?
Adjuvant immunotherapy may be beneficial in selected patients, particularly those without a pathologic complete response, but robust prospective data to isolate the adjuvant contribution are lacking; decisions should consider PD-L1 status, tumor biology, and patient risk/benefit profile.
Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft
Q: What are the most important data points from perioperative immunotherapy trials that clinicians should apply in practice?
Key takeaways include the consistent improvements in pathologic response rates and some signals for improved survival in several perioperative studies, though attributing benefit specifically to induction vs adjuvant phases remains challenging; PD-L1 status remains a useful but not absolute predictor, and decisions should be individualized based on patient fitness, mutation status, and surgical goals.
First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck
Q: Could you walk us through your three-and-a-half-year maintenance case and what it implies for maintenance strategies in extensive-stage disease?
The patient remained on a combination of lurbinectidine and atezolizumab with growth factor support, requiring dose adjustments for fatigue, and eventually discontinued one agent while maintaining response on IO therapy, illustrating the potential for durable disease control with careful management and selection.
First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck
Q: What did you observe about the long-term tail of the survival curve in IO-containing regimens for small cell lung cancer?
The tail on the curve indicates a subset of patients achieving long-term survival, which changes how we view prognosis and supports exploring extended maintenance and continuation of therapy in select cases.
Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
Q: What is your current approach to prophylactic cranial irradiation in limited versus extensive stage disease given newer data and imaging strategies?
The panel acknowledges evolving data, with some leaning away from routine PCI in extensive stage and others awaiting MagFrick data in limited stage to determine net benefit versus toxicity, while emphasizing patient-specific discussion with radiation oncologists.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Lung Cancer Update

What is Lung Cancer Update about and what kind of topics does it cover?

A physician-led interview series that translates cutting-edge thoracic oncology research into practical insights for patient care. Conversations consistently cover tumor biology, targeted therapies, immunotherapy, and emerging diagnostic tools, with real-world clinical decision-making, trial data, and management of treatment-related toxicities highlighted across episodes. Notable strengths include deep clinical expertise from renowned oncologists, practical guidance for implementing new therapies, and a willingness to tackle complex, nuanced cases in NSCLC and SCLC. Listeners are likely clinicians seeking up-to-date treatment strategies and evidence-informed perspectives, as well as researchers looking for synthesis of trial data and transl... more

Where can I find podcast stats for Lung Cancer Update?

Rephonic provides a wide range of podcast stats for Lung Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Lung Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Lung Cancer Update get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Lung Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Lung Cancer Update?

Rephonic provides comprehensive predictive audience data for Lung Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Lung Cancer Update have?

To see how many followers or subscribers Lung Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Lung Cancer Update?

These podcasts share a similar audience with Lung Cancer Update:

1. Gastrointestinal Cancer Update
2. Lung Cancer Considered
3. Two Onc Docs
4. Breast Cancer Update
5. Prostate Cancer Update

How many episodes of Lung Cancer Update are there?

Lung Cancer Update launched 20 years ago and published 359 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Lung Cancer Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Lung Cancer Update?

Rephonic pulls ratings and reviews for Lung Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Lung Cancer Update?

Rephonic provides full transcripts for episodes of Lung Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Lung Cancer Update?

Recent guests on Lung Cancer Update include:

1. Dr. Jamie Chaft
2. Courtney Arn
3. Jamie Carroll
4. Eddie Garon
5. Heather McArthur
6. Lyuda Bazhenova
7. Corey Langer
8. Sunil Gandhi

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days